Bridging D-A type photosensitizers with the azo group to boost intersystem crossing for efficient photodynamic therapy.
Bridging D-A type photosensitizers with the azo group to boost intersystem crossing for efficient photodynamic therapy.
复制标题
DOI:
10.1039/d2sc00381c
复制
发表时间:
2022-04-06
期刊:
影响因子:
8.4
通讯作者:
Zhu C
中科院分区:
文献类型:
--
作者:
Hao B;Wang J;Wang C;Xue K;Xiao M;Lv S;Zhu C
Photodynamic therapy (PDT) has attracted much attention in disease treatments. However, the exploration of a novel method for the construction of outstanding photosensitizers (PSs) with stimuli-responsiveness remains challenging. In this study, we, for the first time, report a novel and effective strategy to boost reactive oxygen species (ROS) generation by bridging donor–acceptor (D–A) type PSs with the azo group. In contrast to the counterpart without azo-bridging, the azo-bridged PSs exhibit remarkably enhanced ROS generation via both type-I and type-II photochemical reactions. Theoretical calculations suggest that azo-bridging leads to a prominent reduction in ΔEST, thereby enabling enhanced ROS generation via efficient intersystem crossing (ISC). The resulting azo-bridged PS (denoted as Azo-TPA-Th(+)) exhibits a particularly strong bactericidal effect against clinically relevant drug-resistant bacteria, with the killing efficiency up to 99.999999% upon white light irradiation. Since azo-bridging generates an azobenzene structure, Azo-TPA-Th(+) can undergo trans-to-cis isomerization upon UV irradiation to form emissive aggregates by shutting down the ISC channel. By virtue of the fluorescence turn-on property of unbound Azo-TPA-Th(+), we propose a straightforward method to directly discern the effective photodynamic bactericidal dose without performing the tedious plate-counting assay. This study opens a brand-new avenue for the design of advanced PSs with both strong ROS generation and stimuli-responsiveness, holding great potential in high-quality PDT with rapid prediction of the therapeutic outcome. A novel and effective strategy is developed for enhanced photosensitization by bridging D–A type photosensitizers with the azo group, holding great potential in high-quality photodynamic therapy with rapid prediction of the therapeutic outcome.
登录
查看更多内容
影响因子:
17.1
作者:
Liu, Zhiyang;Zou, Hang;Tang, Ben Zhong
通讯作者:
Tang, Ben Zhong
DOI:
10.1002/advs.202001750
发表时间:
2021-05
期刊:
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
影响因子:
--
作者:
Li Y;Liu F;Zhang J;Liu X;Xiao P;Bai H;Chen S;Wang D;Sung SHP;Kwok RTK;Shen J;Zhu K;Tang BZ
通讯作者:
Tang BZ
DOI:
10.1016/s1011-1344(02)00279-8
发表时间:
2002-05-01
影响因子:
5.4
作者:
Bourré, L;Thibaut, S;Patrice, T
通讯作者:
Patrice, T
影响因子:
--
作者:
Shen, Liang;Ji, Hong-Fang;Zhang, Hong-Yu
通讯作者:
Zhang, Hong-Yu
影响因子:
15
作者:
Cembran, A;Bernardi, F;Orlandi, G
通讯作者:
Orlandi, G